• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化合并未控制的静脉曲张出血患者的死亡决定因素。

Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding.

作者信息

Kumar Rahul, Kerbert Annarein J C, Sheikh M Faisal, Roth Noam, Calvao Joana A F, Mesquita Monica D, Barreira Ana I, Gurm Haqeeqat S, Ramsahye Komal, Mookerjee Rajeshwar P, Yu Dominic, Davies Neil H, Mehta Gautam, Agarwal Banwari, Patch David, Jalan Rajiv

机构信息

Liver Failure Group, UCL Institute for Liver and Digestive Health, UCL Medical School, Royal Free Campus, London, UK; Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore; Duke-NUS Academic Medical Centre, CGH Campus, Singapore.

Liver Failure Group, UCL Institute for Liver and Digestive Health, UCL Medical School, Royal Free Campus, London, UK.

出版信息

J Hepatol. 2021 Jan;74(1):66-79. doi: 10.1016/j.jhep.2020.06.010. Epub 2020 Jun 16.

DOI:10.1016/j.jhep.2020.06.010
PMID:32561318
Abstract

BACKGROUND & AIMS: Failure to control oesophago-gastric variceal bleeding (OGVB) and acute-on-chronic liver failure (ACLF) are both important prognostic factors in cirrhosis. The aims of this study were to determine whether ACLF and its severity define the risk of death in OGVB and whether insertion of rescue transjugular intrahepatic shunt (TIPS) improves survival in patients with failure to control OGVB and ACLF.

METHODS

Data on 174 consecutive eligible patients, with failure to control OGVB between 2005 and 2015, were collected from a prospectively maintained intensive care unit registry. Rescue TIPS was defined as technically successful TIPS within 72 hours of presentation with failure to control OGVB. Cox-proportional hazards regression analyses were applied to explore the impact of ACLF and TIPS on survival in patients with failure to control OGVB.

RESULTS

Patients with ACLF (n = 119) were significantly older, had organ failures and higher white cell count than patients with acute decompensation (AD, n = 55). Mortality at 42-days and 1-year was significantly higher in patients with ACLF (47.9% and 61.3%) than in those with AD (9.1% and 12.7%, p <0.001), whereas there was no difference in the number of endoscopies and transfusion requirements between these groups. TIPS was inserted in 78 patients (AD 21 [38.2%]; ACLF 57 [47.8%]; p = 0.41). In ACLF, rescue TIPS insertion was an independent favourable prognostic factor for 42-day mortality. In contrast, rescue TIPS did not impact on the outcome of patients with AD.

CONCLUSIONS

This study shows that in patients with failure to control OGVB, the presence and severity of ACLF determines the risk of 42-day and 1-year mortality. Rescue TIPS is associated with improved survival in patients with ACLF.

LAY SUMMARY

Variceal bleeding that is not controlled by initial endoscopy is associated with high risk of death. The results of this study showed that in the occurrence of failure of the liver and other organs defines the risk of death. In these patients, insertion of a shunt inside the liver to drain the portal vein improves survival.

摘要

背景与目的

食管胃静脉曲张破裂出血(OGVB)控制不佳和慢加急性肝衰竭(ACLF)都是肝硬化重要的预后因素。本研究旨在确定ACLF及其严重程度是否决定OGVB患者的死亡风险,以及置入挽救性经颈静脉肝内门体分流术(TIPS)是否能提高OGVB控制不佳合并ACLF患者的生存率。

方法

从一个前瞻性维护的重症监护病房登记处收集了2005年至2015年间174例连续符合条件的OGVB控制不佳患者的数据。挽救性TIPS定义为在出现OGVB控制不佳后72小时内技术成功的TIPS。应用Cox比例风险回归分析来探讨ACLF和TIPS对OGVB控制不佳患者生存的影响。

结果

ACLF患者(n = 119)比急性失代偿(AD,n = 55)患者年龄显著更大,有器官功能衰竭且白细胞计数更高。ACLF患者42天和1年时的死亡率(47.9%和61.3%)显著高于AD患者(9.1%和12.7%,p <0.001),而两组之间的内镜检查次数和输血需求数量没有差异。78例患者接受了TIPS置入(AD组21例[38.2%];ACLF组57例[47.8%];p = 0.41)。在ACLF患者中,置入挽救性TIPS是42天死亡率的独立有利预后因素。相比之下,挽救性TIPS对AD患者的结局没有影响。

结论

本研究表明,在OGVB控制不佳的患者中,ACLF的存在及其严重程度决定了42天和1年死亡率的风险。挽救性TIPS与ACLF患者生存率提高相关。

简要概述

初次内镜检查未能控制的静脉曲张出血与高死亡风险相关。本研究结果表明,肝脏和其他器官功能衰竭的发生决定了死亡风险。在这些患者中,在肝脏内置入分流装置以引流门静脉可提高生存率。

相似文献

1
Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding.肝硬化合并未控制的静脉曲张出血患者的死亡决定因素。
J Hepatol. 2021 Jan;74(1):66-79. doi: 10.1016/j.jhep.2020.06.010. Epub 2020 Jun 16.
2
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.ACLF 会增加再出血和死亡率,但预防性 TIPS 可降低再出血和死亡率。
J Hepatol. 2020 Nov;73(5):1082-1091. doi: 10.1016/j.jhep.2020.04.024. Epub 2020 Apr 24.
3
Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis.内镜治疗及经颈静脉肝内门体分流术与门腔分流术治疗肝硬化胃静脉曲张出血的急诊及择期治疗的随机试验
Surgery. 2015 Jun;157(6):1028-45. doi: 10.1016/j.surg.2014.12.003.
4
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure.对于高危静脉曲张再出血和慢加急性肝衰竭患者,是否进行 TIPS。
Semin Liver Dis. 2023 May;43(2):189-205. doi: 10.1055/a-2107-0576. Epub 2023 Jun 7.
5
[Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].经颈静脉肝内门体分流术治疗肝硬化食管胃底静脉曲张破裂出血:目标人群及时机
Zhonghua Gan Zang Bing Za Zhi. 2017 Jun 20;25(6):402-407. doi: 10.3760/cma.j.issn.1007-3418.2017.06.002.
6
Early use of TIPS in patients with cirrhosis and variceal bleeding.经颈静脉肝内门体分流术在肝硬化并食管胃静脉曲张出血患者中的早期应用。
N Engl J Med. 2010 Jun 24;362(25):2370-9. doi: 10.1056/NEJMoa0910102.
7
Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding.经颈静脉肝内门体分流术治疗急性静脉曲张出血内镜治疗失败后早期死亡的相关因素。
J Hepatol. 1998 Mar;28(3):454-60. doi: 10.1016/s0168-8278(98)80320-6.
8
A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.一项比较经颈静脉肝内门体分流术与氰基丙烯酸酯注射预防胃静脉曲张再出血的前瞻性随机对照试验。
Endoscopy. 2007 Aug;39(8):679-85. doi: 10.1055/s-2007-966591.
9
Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.门静脉分流支和支架位置可预测经颈静脉肝内门体分流术后的生存情况。
World J Gastroenterol. 2014 Jan 21;20(3):774-85. doi: 10.3748/wjg.v20.i3.774.
10
Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.美国急性食管静脉曲张出血住院患者的早期经颈静脉肝内门体分流术
J Gastroenterol Hepatol. 2017 Apr;32(4):852-858. doi: 10.1111/jgh.13593.

引用本文的文献

1
EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implications.欧洲肝脏研究学会研究生课程报告:慢性肝病中的血管生物学及其临床管理意义
JHEP Rep. 2025 Mar 19;7(8):101399. doi: 10.1016/j.jhepr.2025.101399. eCollection 2025 Aug.
2
Long-term outcomes after ICU admission in critically ill patients with liver cirrhosis: An Australian state-wide cohort study.肝硬化重症患者入住重症监护病房后的长期预后:一项澳大利亚全州队列研究。
Hepatol Commun. 2025 Jul 21;9(8). doi: 10.1097/HC9.0000000000000762. eCollection 2025 Aug 1.
3
Management Strategies for Refractory Esophageal Varices.
难治性食管静脉曲张的管理策略
DEN Open. 2025 Jun 19;6(1):e70155. doi: 10.1002/deo2.70155. eCollection 2026 Apr.
4
Clinical efficacy of transjugular intrahepatic portosystemic shunt in treating esophageal variceal bleeding in patients with liver cirrhosis.经颈静脉肝内门体分流术治疗肝硬化患者食管静脉曲张出血的临床疗效
Pak J Med Sci. 2025 Apr;41(4):1138-1144. doi: 10.12669/pjms.41.4.11695.
5
Applications of Hydrogels in Emergency Therapy.水凝胶在急救治疗中的应用。
Gels. 2025 Mar 23;11(4):234. doi: 10.3390/gels11040234.
6
Serum Interleukin-6 Levels may be a Key Determinant of 6-week Further Decompensation Risk in Patients With Cirrhosis and Acute Variceal Bleed: A Proof of Concept Study.血清白细胞介素-6水平可能是肝硬化和急性静脉曲张出血患者6周后再失代偿风险的关键决定因素:一项概念验证研究。
J Clin Exp Hepatol. 2025 May-Jun;15(3):102496. doi: 10.1016/j.jceh.2024.102496. Epub 2025 Jan 2.
7
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Treatment of Bleeding from Cardiofundal and Ectopic Varices in Cirrhosis.经颈静脉肝内门体分流术(TIPS)治疗肝硬化贲门和异位静脉曲张出血
J Clin Med. 2024 Sep 24;13(19):5681. doi: 10.3390/jcm13195681.
8
Critical care outcomes in decompensated cirrhosis: a United States national inpatient sample cross-sectional study.失代偿期肝硬化的重症监护结局:美国全国住院患者样本横断面研究。
Crit Care. 2024 May 7;28(1):150. doi: 10.1186/s13054-024-04938-8.
9
Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension.肝硬化门静脉高压症食管胃底静脉曲张出血的管理指南
J Clin Transl Hepatol. 2023 Dec 28;11(7):1565-1579. doi: 10.14218/JCTH.2023.00061. Epub 2023 Oct 17.
10
Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria.基于 Baveno VII 标准,对经经颈静脉肝内门体分流术(TIPS)治疗并发症失代偿期肝硬化患者的显著补偿。
World J Gastroenterol. 2023 Oct 14;29(38):5383-5394. doi: 10.3748/wjg.v29.i38.5383.